Page 75 - Read Online
P. 75

Zlatkina et al. Vessel Plus 2019;3:7  I  http://dx.doi.org/10.20517/2574-1209.2019.03                                                   Page 9 of 11
                                                                                                    [57]
               complications, while taking into account existing pathological effects that can affect pancreatic β-cells .


               DECLARATIONS
               Authors’ contributions
               Study design, manuscript review: Zlatkina V, Karaya O, Yarmish N, Shalimova A
               Development of methodology: Zlatkina V
               Collection of data, analysis and/or interpretation of data, writing (not revising) all or sections of the
               manuscript: Zlatkina V, Karaya O, Yarmish N, Shalimova A
               Supervision: Shalimova A


               Availability of data and materials
               Not applicable.


               Financial support and sponsorship
               None.


               Conflicts of interest
               All authors declared that there are no conflicts of interest.


               Ethical approval and consent to participate
               Not applicable.

               Consent for publication
               Not applicable.


               Copyright
               © The Author(s) 2019.


               REFERENCES
               1.   Hall E, Dekker Nitert M, Volkov P, Malmgren S, Mulder H, et al. The effects of high glucose exposure on global gene expression and
                   DNA methylation in human pancreatic islets. Mol Cell Endocrinol 2018;472:57-67.
               2.   Bensellam M, Jonas JC, Laybutt DR. Mechanisms of β-cell dedifferentiation in diabetes: recent findings and future research directions J
                   Endocrinol 2018;236:R109-43.
               3.   Robertson RP, Harmon JS, Tanaka Y. Glucose toxicity of the β-cell: cellular and molecular mechanisms. In: Diabetes mellitus. A
                   fundamental and clinical text. 2nd ed. In: Le Roith D, Taylor SI, Olefsky JM, editors. Philadelphia: Lippincott Williams & Wilkins;
                   2000. pp. 125-32.
               4.   Staiger H, Machicao F, Fritsche A, Häring HU. Pathomechanisms of type 2 diabetes genes. Endocr Rev 2009;30:557-85.
               5.   Choe SS, Choi AH, Lee JW, Kim KH, Chung JJ, et al. Chronic activation of liver X receptor induces β-cell apoptosis through
                   hyperactivation of lipogenesis: liver X receptor-mediated lipotoxicity in pancreatic β-cells. Diabetes 2007;56:1534-43.
               6.   Juntilla M, Wofford JA, Birnbaum MJ, Rathmell JC, Koretzky GA. Akt1 and Akt2 are required for alphabetathymocyte survival and
                   differentiation. ProcNatlAcadSci U S A 2007;104:12105-10.
               7.   Huang JP, Huang SS, Deng JY, Hung LM. Impairment of insulin-stimulated Akt/GLUT4 signaling is associated with cardiac contractile
                   dysfunction and aggravates I/R injury in STZ-diabetic rats. J Biomed Sci 2009;16:77.
               8.   Ide T, Shimano H, Yahagi N, Matsuzaka T, Nakakuki M, et al. SREBPs suppress IRS-2-mediated insulin signalling in the liver. Na Cell
                   Biol 2004;6:351-7.
               9.   Pettinelli P, Del Pozo T, Araya J, Rodrigo R, Araya AV, et al. Enhancement in liver SREBP-1c/PPAR-alpha ratio and steatosis in
                   obese patients: correlations with insulin resistance and n-3 long-chain polyunsaturated fatty acid depletion. BiochimBiophysActa
                   2009;1792:1080-6.
               10.  Huo M, Zang HL, Zhang DJ, Wang B, Wu J, et al. Role of increased activity of carbohydrate response element binding protein in
                   excessive lipid accumulation in the liver of type 2 diabetic db/db mouse. Beijing Da Xue Xue Bao Yi Xue Bao 2009;41:307-12. (in
                   Chinese)
               11.  Poitout V, Robertson RP. Glucolipotoxicity: fuel excess and β-cell dysfunction. Endocr Rev 2007;29:351-66.
   70   71   72   73   74   75   76   77   78   79   80